Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in HIMS — Hims & Hers Health, Inc.

CIK 902219 Boston, MA
Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,867,761
-$9,358,829 QoQ
Shares Held
313,463
-67.8% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 507 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 88% None 12%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names. HIMS ranks #12 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,379,025 $747,197,111
2 ZTS
Zoetis Inc.
 9,423,895 $677,201,094
3 TEVA
Teva Pharmaceutical Industries Ltd
 7,671,157 $259,898,795
4 ALKS
Alkermes plc.
 2,814,804 $147,495,727
5 LNTH
Lantheus Holdings, Inc.
 1,013,063 $112,389,207
6 ELAN
Elanco Animal Health Inc
 2,676,050 $65,857,589
7 HLN
Haleon plc
 3,273,583 $30,542,527
8 XERS
Xeris Biopharma Holdings, Inc.
 2,365,103 $18,731,613

All Filings in HIMS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,867,761 313,463
2026-03-31 $20,226,590 974,306
2025-12-31 $36,601,188 1,127,231
2025-09-30 $58,258,926 1,027,132
2025-06-30 $78,653,676 1,577,807
2025-03-31 $25,221,662 853,525
2024-12-31 $82,757,643 3,422,566
2024-09-30 $63,446,104 3,444,414
2024-06-30 $51,710,302 2,561,184
2024-03-31 $25,965,481 1,678,441